ENA 100 (Idhifa 100 mg)
Generic Name: enasidenib
Pill with imprint ENA 100 is Yellow, Capsule-shape and has been identified as Idhifa 100 mg. It is supplied by Celgene Corporation.
Idhifa is used in the treatment of acute myeloid leukemia and belongs to the drug class miscellaneous antineoplastics.
Images for ENA 100
Idhifa
- Generic Name:
- enasidenib
- Imprint:
- ENA 100
- Strength:
- 100 mg
- Color:
- Yellow
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Miscellaneous antineoplastics
- CSA Schedule:
- Unknown
- Labeler / Supplier:
- Celgene Corporation
- National Drug Code (NDC):
- 59572-0710
More about Idhifa (enasidenib)
- Idhifa Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 0 Reviews
- Drug class: miscellaneous antineoplastics
Consumer resources
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
